Non-Small Cell Lung Cancer: Immunotherapy and Chemotherapy Study

We are studying a treatment combining immunotherapy, chemotherapy, and radiotherapy for patients with newly diagnosed non-small cell lung cancer that has spread to a few other areas. The aim is to see if this approach helps patients live longer without their cancer worsening.

>2 years 6-10 visits Efficacy phase (II)No Placebo Standard Medicines InjectionOncologyPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Imfinzi

Imfinzi is a cancer medicine that helps the immune system find and fight tumor cells.

Imjudo

Imjudo is a cancer medicine that helps the immune system find and attack tumor cells.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Durvalumab

Durvalumab is a substance that helps the immune system recognize and attack certain cancers by blocking a protein tumors use to hide.

Tremelimumab

Tremelimumab is a substance that helps the immune system attack certain cancers by blocking a checkpoint that restrains immune responses.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Istituto Europeo Di Oncologia S.r.l.

Medical Oncology

Opera, Italy

Istituto Oncologico Veneto

Medical Oncology

Padova, Italy

I.F.O. Istituti Fisioterapici Ospitalieri

Medical Oncology

Vitinia, Italy

Sponsor: ETOP IBCSG Partners Foundation

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.